Humanized anti-CD24 antibody and application thereof
The invention discloses a humanized anti-CD24 antibody and application thereof, relates to the technical field of biological medicines, and particularly provides a humanized antibody capable of specifically recognizing CD24 and application thereof. According to the invention, an FR region and a cons...
Gespeichert in:
Hauptverfasser: | , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention discloses a humanized anti-CD24 antibody and application thereof, relates to the technical field of biological medicines, and particularly provides a humanized antibody capable of specifically recognizing CD24 and application thereof. According to the invention, an FR region and a constant region of a murine anti-CD24 monoclonal antibody are replaced by a human CDR which retains a variable region of the murine anti-CD24 monoclonal antibody, so that a series of anti-CD24 humanized monoclonal antibodies are obtained. The humanized antibody obtained by the invention has affinity to a CD24 antigen which is basically equivalent to that of a human-mouse chimeric anti-CD24 monoclonal antibody WT, and shows strong in-vivo anti-tumor capability.
本发明公开了人源化抗CD24抗体及其应用,涉及生物医药技术领域,具体地,本发明提供了能够特异性识别CD24的人源化抗体及其应用。本发明将鼠源抗CD24单克隆抗体的FR区和恒定区替换为人源的,保留鼠源抗CD24单克隆抗体可变区的CDR,得到了一系列的抗CD24的人源化单克隆抗体。本发明获得的人源化抗体,具有和人鼠嵌合抗CD24单克隆抗体WT基本相当的对CD24抗原的亲和力,且表现出强劲的体内抗肿瘤能力。 |
---|